Therapeutic targeting of C-terminal binding protein in human cancer

References

• Subramanian T, Chinnadurai G. Association of class I histone deacetylases with transcriptional corepressor CtBP. FEBS Lett 2003; 540:255 - 258
   PubMed Web of Science ®Google Scholar
• Chinnadurai G. CtBP family proteins: more than transcriptional corepressors. Bioessays 2003; 25:9 - 12
   PubMed Web of Science ®Google Scholar
• Boyd JM, Subramanian T, Schaeper U, La Regina M, Bayley S, Chinnadurai G. A region in the C-terminus of adenovirus 2/5 E1a protein is required for association with a cellular phosphoprotein and important for the negative modulation of T24-ras mediated transformation, tumorigenesis and metastasis. EMBO J 1993; 12:469 - 478
   PubMed Web of Science ®Google Scholar
• Schaeper U, Boyd JM, Verma S, Uhlmann E, Subramanian T, Chinnadurai G. Molecular cloning and characterization of a cellular phosphoprotein that interacts with a conserved C-terminal domain of adenovirus E1A involved in negative modulation of oncogenic transformation. Proc Natl Acad Sci USA 1995; 92:10467 - 10471
   PubMed Web of Science ®Google Scholar
• Bergman LM, Blaydes JP. C-terminal binding proteins: emerging roles in cell survival and tumorigenesis. Apoptosis 2006; 11:879 - 888
   PubMed Web of Science ®Google Scholar
• Kuppuswamy M, Vijayalingam S, Zhao LJ, Zhou Y, Subramanian T, Ryerse J, et al. Role of the PLDLS-binding cleft region of CtBP1 in recruitment of core and auxiliary components of the corepressor complex. Mol Cell Biol 2008; 28:269 - 281
   PubMed Web of Science ®Google Scholar
• Zhang Q, Wang SY, Nottke AC, Rocheleau JV, Piston DW, Goodman RH. Redox sensor CtBP mediates hypoxia-induced tumor cell migration. Proc Natl Acad Sci USA 2006; 103:9029 - 9033
   PubMed Web of Science ®Google Scholar
• Grooteclaes M, Deveraux Q, Hildebrand J, Zhang Q, Goodman RH, Frisch SM. C-terminal-binding protein corepresses epithelial and proapoptotic gene expression programs. Proc Natl Acad Sci USA 2003; 100:4568 - 4573
   PubMed Web of Science ®Google Scholar
• Mani-Telang P, Sutrias-Grau M, Williams G, Arnosti DN. Role of NAD binding and catalytic residues in the C-terminal binding protein corepressor. FEBS Lett 2007; 581:5241 - 5246
   PubMed Web of Science ®Google Scholar
• Fjeld CC, Birdsong WT, Goodman RH. Differential binding of NAD+ and NADH allows the transcriptional corepressor carboxyl-terminal binding protein to serve as a metabolic sensor. Proc Natl Acad Sci USA 2003; 100:9202 - 9207
   PubMed Web of Science ®Google Scholar
• Zhang Q, Piston DW, Goodman RH. Regulation of corepressor function by nuclear NADH. Science 2002; 295:1895 - 1897
   PubMed Web of Science ®Google Scholar
• Thio SS, Bonventre JV, Hsu SI. The CtBP2 co-repressor is regulated by NADH-dependent dimerization and possesses a novel N-terminal repression domain. Nucleic Acids Res 2004; 32:1836 - 1847
   PubMed Web of Science ®Google Scholar
• Kumar V, Carlson JE, Ohgi KA, Edwards TA, Rose DW, Escalante CR, et al. Transcription corepressor CtBP is an NAD(+)-regulated dehydrogenase. Mol Cell 2002; 10:857 - 869
   PubMed Web of Science ®Google Scholar
• Balasubramanian P, Zhao LJ, Chinnadurai G. Nicotinamide adenine dinucleotide stimulates oligomerization, interaction with adenovirus E1A and an intrinsic dehydrogenase activity of CtBP. FEBS Lett 2003; 537:157 - 160
   PubMed Web of Science ®Google Scholar
• Kim JH, Youn HD. C-terminal binding protein maintains mitochondrial activities. Cell Death Differ 2009; 16:584 - 592
   PubMed Web of Science ®Google Scholar
• Chinnadurai G. The transcriptional corepressor CtBP: a foe of multiple tumor suppressors. Cancer Res 2009; 69:731 - 734
   PubMed Web of Science ®Google Scholar
• Chen YW, Paliwal S, Draheim K, Grossman SR, Lewis BC. p19Arf inhibits the invasion of hepatocellular carcinoma cells by binding to C-terminal binding protein. Cancer Res 2008; 68:476 - 482
   PubMed Web of Science ®Google Scholar
• Paliwal S, Kovi RC, Nath B, Chen YW, Lewis BC, Grossman SR. The alternative reading frame tumor suppressor antagonizes hypoxia-induced cancer cell migration via interaction with the COOH-terminal binding protein corepressor. Cancer Res 2007; 67:9322 - 9329
   PubMed Web of Science ®Google Scholar
• Paliwal S, Pande S, Kovi RC, Sharpless NE, Bardeesy N, Grossman SR. Targeting of C-terminal binding protein (CtBP) by ARF results in p53-independent apoptosis. Mol Cell Biol 2006; 26:2360 - 2372
   PubMed Web of Science ®Google Scholar
• Mirnezami AH, Campbell SJ, Darley M, Primrose JN, Johnson PW, Blaydes JP. Hdm2 recruits a hypoxia-sensitive corepressor to negatively regulate p53-dependent transcription. Curr Biol 2003; 13:1234 - 1239
   PubMed Web of Science ®Google Scholar
• Mroz EA, Baird AH, Michaud WA, Rocco JW. COOH-terminal binding protein regulates expression of the p16INK4A tumor suppressor and senescence in primary human cells. Cancer Res 2008; 68:6049 - 6053
   PubMed Web of Science ®Google Scholar
• Liu Y, El-Naggar S, Darling DS, Higashi Y, Dean DC. Zeb1 links epithelial-mesenchymal transition and cellular senescence. Development 2008; 135:579 - 588
   PubMed Web of Science ®Google Scholar
• Zhang Q, Yoshimatsu Y, Hildebrand J, Frisch SM, Goodman RH. Homeodomain interacting protein kinase 2 promotes apoptosis by downregulating the transcriptional corepressor CtBP. Cell 2003; 115:177 - 186
   PubMed Web of Science ®Google Scholar
• Nadauld LD, Phelps R, Moore BC, Eisinger A, Sandoval IT, Chidester S, et al. Adenomatous polyposis coli control of C-terminal binding protein-1 stability regulates expression of intestinal retinol dehydrogenases. J Biol Chem 2006; 281:37828 - 37835
   PubMed Web of Science ®Google Scholar
• Phelps RA, Chidester S, Dehghanizadeh S, Phelps J, Sandoval IT, Rai K, et al. A two-step model for colon adenoma initiation and progression caused by APC loss. Cell 2009; 137:623 - 634
   PubMed Web of Science ®Google Scholar
• Kovi RC, Paliwal S, Pande S, Grossman SR. An ARF/CtBP2 complex regulates BH3-only gene expression and p53-independent apoptosis. Cell Death Differ 17:513 - 521
   PubMed Web of Science ®Google Scholar
• Achouri Y, Noel G, Van Schaftingen E. 2-Keto-4-methylthiobutyrate, an intermediate in the methionine salvage pathway, is a good substrate for CtBP1. Biochem Biophys Res Commun 2007; 352:903 - 906
   PubMed Web of Science ®Google Scholar
• Subhi AL, Diegelman P, Porter CW, Tang B, Lu ZJ, Markham GD, et al. Methylthioadenosine phosphorylase regulates ornithine decarboxylase by production of downstream metabolites. J Biol Chem 2003; 278:49868 - 49873
   PubMed Web of Science ®Google Scholar
• Tang B, Kadariya Y, Murphy ME, Kruger WD. The methionine salvage pathway compound 4-methylthio-2-oxobutanate causes apoptosis independent of downregulation of ornithine decarboxylase. Biochem Pharmacol 2006; 72:806 - 815
   PubMed Web of Science ®Google Scholar
• Walser M. Ketoacids in the treatment of uremia. Clin Nephrol 1975; 3:180 - 186
   PubMedGoogle Scholar
• Mitch WE, Abras E, Walser M. Long-term effects of a new ketoacid-amino acid supplement in patients with chronic renal failure. Kidney Int 1982; 22:48 - 53
   PubMed Web of Science ®Google Scholar
• Dilger RN, Kobler C, Weckbecker C, Hoehler D, Baker DH. 2-keto-4-(methylthio)butyric acid (keto analog of methionine) is a safe and efficacious precursor of L-methionine in chicks. J Nutr 2007; 137:1868 - 1873
   PubMed Web of Science ®Google Scholar
• Stipanuk MH. The keto acid of methionine is a safe and efficacious substitute for dietary L-methionine: the answer from chick bioassays. J Nutr 2007; 137:1844 - 1845
   PubMed Web of Science ®Google Scholar
• Burri N, Shaw P, Bouzourene H, Sordat I, Sordat B, Gillet M, et al. Methylation silencing and mutations of the p14ARF and p16INK4a genes in colon cancer. Lab Invest 2001; 81:217 - 229
   PubMed Web of Science ®Google Scholar
• Chinnadurai G, Vijayalingam S, Rashmi R. BIK, the founding member of the BH3-only family proteins: mechanisms of cell death and role in cancer and pathogenic processes. Oncogene 2008; 27:20 - 29
   PubMed Web of Science ®Google Scholar
• Daniel PT, Pun KT, Ritschel S, Sturm I, Holler J, Dorken B, et al. Expression of the death gene Bik/Nbk promotes sensitivity to drug-induced apoptosis in corticosteroid-resistant T-cell lymphoma and prevents tumor growth in severe combined immunodeficient mice. Blood 1999; 94:1100 - 1107
   PubMed Web of Science ®Google Scholar
• Sturm I, Stephan C, Gillissen B, Siebert R, Janz M, Radetzki S, et al. Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma. Cell Death Differ 2006; 13:619 - 627
   PubMed Web of Science ®Google Scholar
• Castells A, Ino Y, Louis DN, Ramesh V, Gusella JF, Rustgi AK. Mapping of a target region of allelic loss to a 0.5 cM interval on chromosome 22q13 in human colorectal cancer. Gastroenterology 1999; 117:831 - 837
   PubMed Web of Science ®Google Scholar
• Zhu H, Zhang L, Dong F, Guo W, Wu S, Teraishi F, et al. Bik/NBK accumulation correlates with apoptosis-induction by bortezomib (PS-341, Velcade) and other proteasome inhibitors. Oncogene 2005; 24:4993 - 4999
   PubMed Web of Science ®Google Scholar
• Radetzki S, Kohne CH, von Haefen C, Gillissen B, Sturm I, Dorken B, et al. The apoptosis promoting Bcl-2 homologues Bak and Nbk/Bik overcome drug resistance in Mdr-1-negative and Mdr-1-overexpressing breast cancer cell lines. Oncogene 2002; 21:227 - 238
   PubMed Web of Science ®Google Scholar
• Xie X, Xia W, Li Z, Kuo HP, Liu Y, Ding Q, et al. Targeted expression of BikDD eradicates pancreatic tumors in noninvasive imaging models. Cancer Cell 2007; 12:52 - 65
   PubMed Web of Science ®Google Scholar
• Zou Y, Peng H, Zhou B, Wen Y, Wang SC, Tsai EM, et al. Systemic tumor suppression by the proapoptotic gene bik. Cancer Res 2002; 62:8 - 12
   PubMed Web of Science ®Google Scholar
• Jin W, Scotto KW, Hait WN, Yang JM. Involvement of CtBP1 in the transcriptional activation of the MDR1 gene in human multidrug resistant cancer cells. Biochem Pharmacol 2007; 74:851 - 859
   PubMed Web of Science ®Google Scholar
• Walser M, Coulter AW, Dighe S, Crantz FR. The effect of keto-analogues of essential amino acids in severe chronic uremia. J Clin Invest 1973; 52:678 - 690
   PubMed Web of Science ®Google Scholar
• Hildebrand JD, Soriano P. Overlapping and unique roles for C-terminal binding protein 1 (CtBP1) and CtBP2 during mouse development. Mol Cell Biol 2002; 22:5296 - 5307
   PubMed Web of Science ®Google Scholar
• Lowe SW, Cepero E, Evan G. Intrinsic tumour suppression. Nature 2004; 432:307 - 315
   PubMed Web of Science ®Google Scholar
• Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP, et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 1998; 282:1497 - 1501
   PubMed Web of Science ®Google Scholar
• Soule HD, Maloney TM, Wolman SR, Peterson WD Jr, Brenz R, McGrath CM, et al. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 1990; 50:6075 - 6086
   PubMed Web of Science ®Google Scholar
• Taniguchi T, Garcia-Higuera I, Xu B, Andreassen PR, Gregory RC, Kim ST, et al. Convergence of the fanconi anemia and ataxia telangiectasia signaling pathways. Cell 2002; 109:459 - 472
   PubMed Web of Science ®Google Scholar